Literature DB >> 33589600

SChLAP1 promotes prostate cancer development through interacting with EZH2 to mediate promoter methylation modification of multiple miRNAs of chromosome 5 with a DNMT3a-feedback loop.

Kai Huang1, Yuxin Tang2.   

Abstract

This study aimed to investigate the mechanism of SChLAP1 (second chromosome locus associated with prostate-1) on microRNA expression in prostate cancer. Differential expression of lncRNAs and microRNA prostate cancer cells were predicted by informatics and confirmed by qRT-PCR. SChLAP1-interacting proteins were characterized by RNA pull-down combined with western blotting, which was verified using RIP and qPCR analysis. Then ChIP assay and DNA pull-down were used to validate the binding of DNMT3a and HEK27me3 with miRNA gene promoters. Target genes of miRNAs were bioinformatically predicted and validated by dual-luciferase reporter assays. The tumorigenicity of prostate cancer cells was assessed using the cancer cell line-based xenograft (CDX) model. We found that SChLAP1 expression was significantly elevated in prostate cancer tissues and cell lines, which was negatively correlated with miR-340 expression. SChLAP1 directly binds with EZH2 and repressed multiple miRNA expression on chromosome 5 including the miR-340-3p in prostate cancer cells through recruiting H3K27me3 to mediate promoter methylation modification of miR-340-5p/miR-143-3p/miR-145-5p to suppress gene transcription. Moreover, DNMT3a was one of the common target genes of miR-340-5p/miR-143-3p/miR-145-5p in prostate cancer cells. And SChLAP1/EZH2 could also promote prostate cancer tumor development via the interaction of microRNA-DNMT3a signaling pathways in xenograft nude mice. Altogether, our results suggest that SChLAP1 enhanced the proliferation, migration, and tumorigenicity of prostate cancer cells through interacting with EZH2 to recruit H2K27me3 and mediate promoter methylation modification of miR-340-5p/miR-143-3p/miR-145-5p with a DNMT3a-feedback loop.

Entities:  

Year:  2021        PMID: 33589600      PMCID: PMC7884413          DOI: 10.1038/s41419-021-03455-8

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  31 in total

1.  SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer.

Authors:  Jianping Li; Zhipeng Zhang; Li Xiong; Chuan Guo; Tao Jiang; Lilan Zeng; Ge Li; Juan Wang
Journal:  Biochem Biophys Res Commun       Date:  2017-04-08       Impact factor: 3.575

2.  MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.

Authors:  Kai Huang; Yuxin Tang; Leye He; Yingbo Dai
Journal:  Oncol Rep       Date:  2015-11-26       Impact factor: 3.906

3.  miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.

Authors:  Olivia Larne; Zandra Hagman; Hans Lilja; Anders Bjartell; Anders Edsjö; Yvonne Ceder
Journal:  Carcinogenesis       Date:  2015-05-12       Impact factor: 4.944

Review 4.  The diverse roles of DNA methylation in mammalian development and disease.

Authors:  Maxim V C Greenberg; Deborah Bourc'his
Journal:  Nat Rev Mol Cell Biol       Date:  2019-08-09       Impact factor: 94.444

5.  miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells.

Authors:  Shuai Huang; Wei Guo; Yubo Tang; Dong Ren; Xuenong Zou; Xinsheng Peng
Journal:  Oncol Rep       Date:  2012-09-04       Impact factor: 3.906

Review 6.  Epidemiology of Prostate Cancer.

Authors:  Prashanth Rawla
Journal:  World J Oncol       Date:  2019-04-20

7.  Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells.

Authors:  Xiaofu Qiu; Wei Wang; Bijun Li; Bo Cheng; Kangjian Lin; Jian Bai; Huanhui Li; Guosheng Yang
Journal:  BMC Cancer       Date:  2019-01-08       Impact factor: 4.430

8.  microRNA Expression Profiling in Young Prostate Cancer Patients.

Authors:  Vladimir A Valera; Rafael Parra-Medina; Beatriz A Walter; Peter Pinto; Maria J Merino
Journal:  J Cancer       Date:  2020-04-07       Impact factor: 4.207

9.  CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression.

Authors:  Zhenguo Liu; Yaqun Yu; Zebing Huang; Yi Kong; Xingwang Hu; Wei Xiao; Jun Quan; Xuegong Fan
Journal:  Cell Death Dis       Date:  2019-11-27       Impact factor: 8.469

Review 10.  Molecular alterations associated with prostate cancer.

Authors:  Herney Andres Garcia Perdomo; James A Zapata-Copete; Adalberto Sanchez
Journal:  Cent European J Urol       Date:  2018-03-16
View more
  8 in total

Review 1.  Transcriptome analysis provides critical answers to the "variants of uncertain significance" conundrum.

Authors:  Mackenzie D Postel; Julie O Culver; Charité Ricker; David W Craig
Journal:  Hum Mutat       Date:  2022-05-18       Impact factor: 4.700

2.  Src-homology domain 2 containing protein tyrosine phosphatase-1 (SHP-1) directly binds to proto-oncogene tyrosine-protein kinase Src (c-Src) and promotes the transcriptional activation of connexin 43 (Cx43).

Authors:  YiHao Liu; Meng Dai; PengHui Yang; Li Cao; Li Lu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Whole-genome-scale identification of novel non-protein-coding RNAs controlling cell proliferation and survival through a functional forward genetics strategy.

Authors:  D P Tonge; D Darling; F Farzaneh; G T Williams
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

4.  miR-145-5p Inhibits Neuroendocrine Differentiation and Tumor Growth by Regulating the SOX11/MYCN Axis in Prostate cancer.

Authors:  Shuya Ji; Yi Shi; Lin Yang; Feng Zhang; Yong Li; Feng Xu
Journal:  Front Genet       Date:  2022-03-09       Impact factor: 4.599

5.  A comprehensive analysis of ncRNA-mediated interactions reveals potential prognostic biomarkers in prostate adenocarcinoma.

Authors:  Li Guo; Yihao Kang; Yiqi Xiong; Lin Jia; Xiaoqiang Yan; Daoliang Xia; Jiafeng Yu; Jun Wang; Tingming Liang
Journal:  Comput Struct Biotechnol J       Date:  2022-07-14       Impact factor: 6.155

6.  Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease.

Authors:  Hong Yuen Wong; Quanhu Sheng; Amanda B Hesterberg; Sarah Croessmann; Brenda L Rios; Khem Giri; Jorgen Jackson; Adam X Miranda; Evan Watkins; Kerry R Schaffer; Meredith Donahue; Elizabeth Winkler; David F Penson; Joseph A Smith; S Duke Herrell; Amy N Luckenbaugh; Daniel A Barocas; Young J Kim; Diana Graves; Giovanna A Giannico; Jeffrey C Rathmell; Ben H Park; Jennifer B Gordetsky; Paula J Hurley
Journal:  Nat Commun       Date:  2022-10-13       Impact factor: 17.694

7.  Lnc-STYK1-2 regulates bladder cancer cell proliferation, migration, and invasion by targeting miR-146b-5p expression and AKT/STAT3/NF-kB signaling.

Authors:  Ranran Dai; Qingping Jiang; You Zhou; Ruifeng Lin; Hai Lin; Yumin Zhang; Jinhu Zhang; Xingcheng Gao
Journal:  Cancer Cell Int       Date:  2021-07-31       Impact factor: 5.722

8.  Epstein-Barr Virus Infection Alone or Jointly with Human Papillomavirus Associates with Down-Regulation of miR-145 in Oral Squamous-Cell Carcinoma.

Authors:  Chukkris Heawchaiyaphum; Tipaya Ekalaksananan; Natcha Patarapadungkit; Suchin Worawichawong; Chamsai Pientong
Journal:  Microorganisms       Date:  2021-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.